为了获得访问"阿拉丁铁蛋"实时聊天框的流畅支持体验,建议您使用Chrome浏览器或选择360浏览器极速模式(如何切换极速模式?),感谢您选择我们!

塞来昔布

选择性环氧合酶2(COX-2)抑制剂。非甾体抗炎药。
规格或纯度: ≥99%
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
C129279-100mg
100mg 现货 Stock Image
C129279-5g
5g 现货 Stock Image
C129279-10g
10g 现货 Stock Image
C129279-25g
25g 现货 Stock Image
C129279-100g
100g 现货 Stock Image
C129279-500g
500g 现货 Stock Image

基本描述

别名 塞内昔布|4-[5-(4-甲苯基)-3-(三氟甲基)-1H-吡唑-1-基]甲磺酰胺|5-(4-甲苯基)-1-(4-磺酰基苯基)-3-(三氟甲基)吡唑
英文别名 celecoxib|169590-42-5|Celebrex|Celebra|Onsenal|Celecox|Celocoxib|Xilebao|184007-95-2|SC 58635|SC-58635|YM177|4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE|4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonam
规格或纯度 ≥99%
英文名称 Celecoxib
生化机理 Celecoxib is a selective cyclooxygenase-2 (Cox-2) inhibitor (IC50 = 40 nM) with low sensitivity against Cox-1. Celecoxib shows an anti-proliferative effect on nasopharyngeal carcinoma (NPC) cell lines including HNE1 (IC50 = 32.86 μM) and CNE1-LMP1 (IC50 = 61.31 μM).Selective COX-2 inhibitor (IC 50 values are 15 and 0.04 μM for COX-1 and COX-2 respectively). Non-steroidal anti-inflammatory drug. Enhances tumor cell apoptosis in vivo . Orally active.
储存温度 -20°C储存
运输条件 超低温冰袋运输
备注 100mg卖完停产,不再备货;如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。
产品介绍

Celecoxib是环氧合酶-2(COX-2)选择性抑制剂,IC50为40 nM。A selective Cox-2 inhibitor

Celecoxib is a selective COX-2 inhibitor with IC50 of 40 nM.
A selective Cox-2 inhibitor

产品属性

ALogP 3.4

名称和标识符

EC号 685-962-5
IUPAC Name 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
INCHI InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)
InChi Key RZEKVGVHFLEQIL-UHFFFAOYSA-N
Canonical SMILES CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
Isomeric SMILES CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
WGK Germany 3
RTECS DB2944937
关联CAS 169590-42-5
PubChem CID 2662
NSC Number 719627
MeSH Entry Terms 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide;Celebrex;celecoxib;SC 58635;SC-58635;SC58635
分子量 381.37

化学和物理性质

溶解性 Soluble in DMSO (76 mg/ml at 25 °C), methanol, ethanol (33 mg/ml at 25 °C), water (<1 mg/ml at 25 °C), and dichloromethane., Soluble in DMSO (76 mg/ml at 25 °C), methanol, ethanol (33 mg/ml at 25 °C), water (<1 mg/ml at 25 °C), and dichloromethane
敏感性 对热、光线敏感
熔点 163 °C

安全和危险性(GHS)

象形图
ghs08

Health Hazard

信号词 Danger
危险声明 H360: May damage fertility or the unborn child
预防措施声明 P280,P405,P501,P203,P318
WGK Germany 3
RTECS DB2944937
Merck Index 1956

质检证书(COA)

质检报告(COA)

输入批号以搜索COA:

相关文档

质检报告COA

请输入批号:


产品问答

产品问答

登录提交问题 Hover me 请先登录再提交问题
您提交该产品问题后,我们会在1-2个工作日内给您答复,您可以登录"我的账号",然后点击"我的产品问答"查看答案

参考文献

1. Penning TD, Talley JJ, Bertenshaw SR, Carter JS, Collins PW, Docter S, Graneto MJ, Lee LF, Malecha JW, Miyashiro JM et al..  (1997)  Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib)..  J Med Chem,  40  (9):  (1347-65).  [PMID:9135032]
2. Naji S et al..  (2019)  Cadmium Induces Migration of Colon Cancer Cells: Roles of Reactive Oxygen Species, P38 and Cyclooxygenase-2..  Cell Physiol Biochem,  52  (6):  (1517-1534).  [PMID:31120230]
3. Chen L et al..  (2017)  L161982 alleviates collagen-induced arthritis in mice by increasing Treg cells and down-regulating Interleukin-17 and monocyte-chemoattractant protein-1 levels..  BMC Musculoskelet Disord,  18  ():  (462).  [PMID:29145862]
4. Harati R et al..  (2020)  Loss of miR-101-3p Promotes Transmigration of Metastatic Breast Cancer Cells through the Brain Endothelium by Inducing COX-2/MMP1 Signaling..  Pharmaceuticals (Basel),  13  (7):  ().  [PMID:32645833]
5. Dey R & Bishayi B.  (2020)  TLR-2 neutralization potentiates microglial M1 to M2 switching by the combinatorial treatment of ciprofloxacin and dexamethasone during S. aureus infection..  J Neuroimmunol,  344  ():  (577262).  [PMID:32450430]